Skip to main content
Onconic Therapeutics Inc. logo

Onconic Therapeutics Inc. — Investor Relations & Filings

Ticker · 476060 ISIN · KR7476060009 KO Manufacturing
Open in API
Filings indexed 122 across all filing types
Latest filing 2026-04-22 Investor Presentation
Country KR South Korea
Listing KO 476060

About Onconic Therapeutics Inc.

http://onconic.co.kr/

Onconic Therapeutics Inc., established in 2020, is a biopharmaceutical company specializing in the research and development of innovative drugs. A subsidiary of Jeil Pharmaceutical, the company focuses on creating novel treatments for cancer and gastrointestinal disorders, including gastroesophageal reflux disease. Its development strategy prioritizes therapeutics for conditions with high unmet medical needs and significant market potential. Onconic Therapeutics actively advances its pipeline of drug candidates through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 1% confidence The document is an announcement of an upcoming investor relations event (‘기업설명회(IR) 개최’), providing date, location, participants, purpose, and posting details of IR materials. It is not a financial report itself but an investor presentation event notice, matching the Investor Presentation category.
2026-04-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled "임원ㆍ주요주주 특정증권등 소유상황보고서" which details changes in ownership of securities by a company executive (executive shareholdings, acquisition/disposition dates and quantities). This matches the definition of a Director's Dealing report (insider transactions by directors/executives). It is not an annual or interim report, nor an earnings release or proxy statement, but a personal share transaction filing. Therefore, it should be classified as DIRS.
2026-04-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory report titled "임원ㆍ주요주주 특정증권등 소유상황보고서" (Report on ownership of specific securities by officers and major shareholders). It details the holdings and transactions (stock purchase claim exercises) by an executive (director) in the issuer, including share counts before and after, dates, and transaction reasons. This matches the insider trading/personal share transaction filings by directors. Therefore, it is classified as Director's Dealing (DIRS).
2026-04-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is an insider securities ownership report (“임원ㆍ주요주주 특정증권등 소유상황보고서”) filed by a company executive to the Financial Services Commission and Korea Exchange. It details the director’s shareholdings, changes in holdings, acquisition dates, and related personal information. This matches the “Director’s Dealing (DIRS)” category, which covers personal share transactions by company directors and executives.
2026-04-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean insider ownership report (“임원ㆍ주요주주 특정증권등 소유상황보고서”) detailing changes in shareholdings of a company executive (insider) filed with the Financial Services Commission and Korea Exchange. This matches the definition for Director’s Dealing (insider trades by company directors/executives).
2026-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (“Report on Ownership Status of Certain Securities by Executive/Principal Shareholder”) filed with the Securities and Exchange Commission and Korea Exchange. It details changes in shareholdings by an executive (김진성), including purchase and sale dates, share counts, and percentage ownership. This is a classic insider trading/insider share transaction report by a director/executive, matching the definition of Director’s Dealing (DIRS).
2026-04-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.